Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
Digital Balancing innovation and implementation: Embracing agentic A... A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.
Market Access Balancing efficiency with risks: How biopharma companies can... AI technologies can enable companies to program, rather than write, submissions to health authorities.
Digital Partner Content Axtria Ignite 2025: Leading in an Agentic Era Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Digital From 0.1% to infinity: How increasingly larger GPT models ar... Using GPT can drastically increase the probability of success in the process of finding new molecules that can be used for drugs.
News EMA seeks input on virtual alternative to animal test EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.